So Adamas has failed spectacularly with their PLID drug. That doesn’t mean anything if there are other companies willing to buy/partner for Elto, but it really doesn’t help our cause. If Adamas’ drug had gone bonkers, we would have spun off Elto already. But it only takes ones company to overpay for a drug.
(0)
(0)
Amarantus Bioscience Holdings (AMBS) Stock Research Links